CN101804183A - Medicine for treating coronary heart disease - Google Patents
Medicine for treating coronary heart disease Download PDFInfo
- Publication number
- CN101804183A CN101804183A CN201010183017A CN201010183017A CN101804183A CN 101804183 A CN101804183 A CN 101804183A CN 201010183017 A CN201010183017 A CN 201010183017A CN 201010183017 A CN201010183017 A CN 201010183017A CN 101804183 A CN101804183 A CN 101804183A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- medicine
- heart disease
- coronary heart
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
The invention discloses a medicine for treating the coronary heart disease. The medicine is characterized in that the medicine is prepared with the following materials in part by weight: 1 to 20 parts of American ginseng, 1 to 18 parts of antler, 1 to 20 parts of lucid ganoderma, 1 to 30 parts of campanumaea pilosula, 1 to 30 parts of astragalus root, 1 to 20 parts of pseudo-ginseng, 22 parts of Szechuan lovage rhizome, 25 parts of the root of red-rooted salvia, 1 to 22 parts of red paeony root, 1 to 22 parts of pepperweed seed, 1 to 22 parts of medicinal cyathula root, 1 to 25 parts of dwarf lilyturf tuber, 1 to 20 parts of zedoary, 1 to 20 parts of common burreed rhizome, 1 to 22 parts of epimedium herb, 1 to 25 parts of Chinese angelica, 1 to 20 parts of safflower and 1 to 30 parts of peach seed. The invention has a remarkable curative effect, and can take effect in one to two weeks for patients with the coronary heart disease, and the treatment cycle is three months; as treatment continues, 70 percent of people can be cured in two treatment cycles, 20 percent of people can be completely or nearly recovered within five treatment cycles, the effect on about 10 percent of people is poor, but the original state can be kept.
Description
Technical field
The invention belongs to the technical field of Chinese medicine preparation, is exactly a kind of medicine for the treatment of coronary heart disease specifically.
Background technology
Along with the raising of people's living standard, rhythm of life is fast, and physical work reduces day by day, dietary structure is tending towards high heat, high fatization., multiple gradually, become commonly encountered diseases in the modern life.At present modern medicine has more research to cause of coronary heart disease mechanism, and major part thinks due to " three-hypers ", i.e. hypertension and hyperlipidemia and hyperglycemia.Clinically treat by coronary artery dilating, blood pressure lowering, blood lipid-lowering medicine mostly, the patient " once falls ill lifelong medication ".The traditional Chinese medical science is in the accumulation that has had several thousand aspect the treatment of coronary heart disease.Just adopt such as Flos Carthami as far back as the period Tang Dynasty, Radix Salviae Miltiorrhizae, Rhizoma Chuanxiong, Chinese medicines such as blood circulation promoting and blood stasis dispelling such as Radix Notoginseng are taked clinical syndrome differentiation to execute and are controlled, and obtain effect preferably.At present the treatment by Chinese herbs cardiovascular and cerebrovascular disease prescription many, have greater advantage.The present invention has carried out clinical summary and perfect for many years on the basis of the red unit of ancient Chinese prescription hat research.The inventor confirms that human body yin-yang balancing is the foundation stone that the people is survived.The generation of any disease can be found evidence aspect yin and yang imbalance.The generation of coronary heart disease mainly is a yin and yang imbalance, and evil impouring human body is in causing outward.Because due to the insufficiency of vital energy and blood, unable circulation watch box.The present invention provides a kind of according to this mechanism can thoroughly effect a radical cure the medicine of coronary heart disease.
Summary of the invention
Technical scheme of the present invention is: a kind of medicine for the treatment of coronary heart disease is characterized in that: it is to be made by the raw material of following weight parts: Radix Panacis Quinquefolii 1-20, Cornu Cervi Pantotrichum 1-18, Ganoderma 1-20, Radix Codonopsis 1-30, Radix Astragali 1-30, Radix Notoginseng 1-20, Rhizoma Chuanxiong 22, Radix Salviae Miltiorrhizae 25, Radix Paeoniae Rubra 1-22, Semen Lepidii (Semen Descurainiae) 1-22, Radix Cyathulae 1-22, Radix Ophiopogonis 1-25, Rhizoma Curcumae 1-20, RHZOMA SPARGANII 1-20, Herba Epimedii 1-22 Radix Angelicae Sinensis 1-25 Flos Carthami 1-20 Semen Persicae 1-30.Based on the medication custom of traditional monarch, new breakthrough has been arranged again in the side.Adopt many monarchs, many ministers, many assistants, the balance compatibility mode that makes more.Be applicable to multiple crowd, avoid drug resistance because of different living habit or daily medication generation.The present invention is with Flos Carthami, Radix Salviae Miltiorrhizae, and Rhizoma Chuanxiong, promoting blood circulation to disperse blood clots and relieves pain medicines such as Radix Notoginseng, Radix Paeoniae Rubra, Rhizoma Curcumae, RHZOMA SPARGANII, Semen Persicae Radix Angelicae Sinensis are monarch drug, invigorate blood circulation to reach, enrich blood, blood stasis dispelling, analgesic main purpose; Getting invigorating QI and tranquilization medicines such as Radix Ginseng, Radix Panacis Quinquefolii, Radix Codonopsis, the Radix Astragali, Ganoderma is ministerial drug, and in the hope of reaching invigorating primordial QI, the Fructus Alpiniae Oxyphyllae of calming the nerves is promoted the production of body fluid and nourished blood, and benefit is defended consolidating superficial resistance, supports the effect of monarch drug; Get yang-tonifying drug Herba Epimedii, Cornu Cervi Pantotrichum kidney invigorating and YANG supporting, expelling wind and removing dampness; Get YIN-tonifying drug nourishing lung-YIN Radix Ophiopogonis, reinforcing stomach reg fluid, the relieving restlessness that clears away heart-fire, loosening bowel to relieve constipation; By tonifying both YIN and YANG, reach the purpose of assisting a ruler in governing a country monarch drug and ministerial drug; Get Radix Cyathulae, eliminating blood stasis and inducing menstruation, easing joint movement, inducing diuresis for treating stranguria syndrome, conducting blood to flow downwards; The Semen Lepidii (Semen Descurainiae) eliminating pathogen from the lung for relieving asthma, inducing diuresis to remove edema, Radix Cyathulae and Semen Lepidii (Semen Descurainiae) guide medicine capable, are messenger drug.Compared with prior art, the invention has the advantages that: 1, based on Traditional Chinese medical theory, the effect of refinement monarch avoids the single Chinese medicine scope of application narrower, and the risk of the excessive generation of dosage; 2, the traditional treatment coronary heart disease several aspects of blood circulation promoting and blood stasis dispelling that are confined to enrich blood, the present invention breaks through thinking limitation, by QI invigorating, the giving young employees remedial-courses in general knowledge and vocational skills negative and positive.Make curative effect clearer and more definite, effectively.3, pure drug matching, no hormone and mineral substance etc. contain the medicine of heavy metal, and side effect is little; 4, cheap.Most of Chinese medicine is all very common, is convenient to buy, and the patient easily accepts; 5, dose is little, taking convenience.Taking three every day gets final product.The present invention can make dosage forms such as syrup, powder, the watered pill, honeyed pill.Medicine optimal proportion of the present invention is: Radix Panacis Quinquefolii 10, Cornu Cervi Pantotrichum 10, Ganoderma 10, Radix Codonopsis 10, the Radix Astragali 10, Radix Notoginseng 10, Rhizoma Chuanxiong 10, Radix Salviae Miltiorrhizae 10, Radix Paeoniae Rubra 10, Semen Lepidii (Semen Descurainiae) 10, Radix Cyathulae 10, Radix Ophiopogonis 10, Rhizoma Curcumae 10, RHZOMA SPARGANII 10, Herba Epimedii 10 Radix Angelicae Sinensis 10 Flos Carthamis 10 Semen Persicaes 10.
The specific embodiment: get medicine of the present invention in proportion.Embodiment 1: processing powder is broken into 100 order fine powders, fully mixes.Embodiment 2: get suitable quantity of water, be not advisable to have medical material.Decoct secondary, each 1 hour.Twice decoction liquor mixed concentrated.Add dense syrup, make syrup.Embodiment 3: processing powder is broken into 100 order fine powders, fully mixes.Add entry or honey, make the watered pill or honeyed pill.Concrete mode: get theoretical crude drug amount 5-10g, directly take, or add dissolved in boiled water, soak after 20-30 minute and drink.Take every day three times, a week takes effect, and has no side effect.Be part clinical case data below, be used for proving curative effect of the present invention.
Hongqiao District Jia Yuan Dongli, example 1 Lee * * man 55 Tianjin consultation time: on May 4th, 2005.Upon somebody's introduction, see a doctor in Fenyang of hiring a car to from Tianjin.Main suit's hypertension, hyperlipidemia 10 years, with coronary heart disease, pareordia angor just may take place after standing for a long time in sitting, now takes the first aid pharmaceutical quantities near maximal dose, and slightly little then symptom does not have improvement.Take 1 week of Chinese medicine back check of the present invention, during taking angina pectoris symptom does not take place, the patient is very delight; After taking medicine through 3 weeks, coronary heart disease symptom is eliminated again, and according to advising, changes food low grade fever low fat food.2005 to 2008, pareordia angor symptom did not take place again.
Hongqiao District Jia Yuan Dongli, example 2 Lee * * woman age 57 Tianjin consultation time: on May 4th, 2005.Upon somebody's introduction, see a doctor with husband Fenyang of hiring a car to from Tianjin, main suit's idol has feels a pain in the chest when breathing stomachache.Through being diagnosed as coronary heart disease in earlier stage, blood pressure is normal.No history of past illness does not have hereditary history.Take Chinese medicine after 3 weeks, and advise food low grade fever low fat food.2005 so far, follows up a case by regular visits to and do not have recurrence.
Example 3 Yan * * man age 52 Shanxi Yang Jiazhuan township, Fenyang City village village consultation time on March 17th, 2010.Because of coronary heart disease is in hospital, need carry out bypass surgery.Poor because of family, do not implement bypass surgery.After leaving hospital from local front three hospital, see a doctor midway.Clinical definite is serious coronary heart disease, takes 5 weeks of Chinese medicine and takes medicine, advise the alleviating alcohol addiction of lying up, go on a diet, ban on opium-smoking and the opium trade to have a surplus January simultaneously after,, occur once causing being close to rehabilitation outside the tachycardia because of house hold affairs anxiety, anger except once.
Village's consultation time on August 22nd, 2006 at the bottom of the wall of south, Li Jiazhuan township, Fenyang City, 3 * * of example man age 47 Shanxi.Stomachache thinks it is gastric ulcer for many years, and by the agency of is seen a doctor.Clinical eliminating stomach ulcer is confirmed as coronary heart disease, takes 3 weeks of Chinese medicine and takes medicine, and advises the alleviating alcohol addiction of going on a diet, ban on opium-smoking and the opium trade simultaneously.The so-called stomachache of pareordia phenomenon does not appear in three weeks back check again, returns to one's perfect health.
Use example surplus the clinical treatment 139 of the present invention, evident in efficacy, for patients with coronary heart disease, one or two week got final product produce effects, and the general treatment cycle is 3 months; Along with treatment continuity, 70% crowd can cure in two cycles of treatment, and 20% crowd returns to one's perfect health in 5 treatment cycle or near rehabilitation., about 10% crowd then produce effects is not obvious, but can remain stationary.
Claims (2)
1. medicine for the treatment of coronary heart disease, it is characterized in that: it is to be made by the raw material of following weight parts: Radix Panacis Quinquefolii 1-20, Cornu Cervi Pantotrichum 1-18, Ganoderma 1-20, Radix Codonopsis 1-30, Radix Astragali 1-30, Radix Notoginseng 1-20, Rhizoma Chuanxiong 22, Radix Salviae Miltiorrhizae 25, Radix Paeoniae Rubra 1-22, Semen Lepidii (Semen Descurainiae) 1-22, Radix Cyathulae 1-22, Radix Ophiopogonis 1-25, Rhizoma Curcumae 1-20, RHZOMA SPARGANII 1-20, Herba Epimedii 1-22 Radix Angelicae Sinensis 1-25 Flos Carthami 1-20 Semen Persicae 1-30.
2. a kind of medicine for the treatment of coronary heart disease according to claim 1 is characterized in that: various Chinese herbal medicine are made syrup, the watered pill, honeyed pill or powder.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2010101830177A CN101804183B (en) | 2010-05-26 | 2010-05-26 | Medicine for treating coronary heart disease |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2010101830177A CN101804183B (en) | 2010-05-26 | 2010-05-26 | Medicine for treating coronary heart disease |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101804183A true CN101804183A (en) | 2010-08-18 |
CN101804183B CN101804183B (en) | 2011-06-29 |
Family
ID=42606243
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2010101830177A Expired - Fee Related CN101804183B (en) | 2010-05-26 | 2010-05-26 | Medicine for treating coronary heart disease |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101804183B (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103977244A (en) * | 2014-06-06 | 2014-08-13 | 任杰 | Traditional Chinese medicine for treating coronary heart disease |
CN104474129A (en) * | 2014-11-26 | 2015-04-01 | 张治伦 | Medicinal formula for treating coronary heart disease and use method thereof |
CN105796789A (en) * | 2014-12-14 | 2016-07-27 | 张雪松 | Traditional Chinese medicine preparation for treating coronary heart disease |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1124153C (en) * | 2001-08-31 | 2003-10-15 | 石家庄以岭药业股份有限公司 | Medicinal composition for restoring cardiac collaterals and its application |
CN1148211C (en) * | 2001-01-14 | 2004-05-05 | 刘红 | Medicine for treating congestive heart failure |
CN101396543A (en) * | 2008-10-25 | 2009-04-01 | 宁甲保 | Pure traditional Chinese medicine preparation for treating cardio-cerebrovascular disease |
-
2010
- 2010-05-26 CN CN2010101830177A patent/CN101804183B/en not_active Expired - Fee Related
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1148211C (en) * | 2001-01-14 | 2004-05-05 | 刘红 | Medicine for treating congestive heart failure |
CN1124153C (en) * | 2001-08-31 | 2003-10-15 | 石家庄以岭药业股份有限公司 | Medicinal composition for restoring cardiac collaterals and its application |
CN101396543A (en) * | 2008-10-25 | 2009-04-01 | 宁甲保 | Pure traditional Chinese medicine preparation for treating cardio-cerebrovascular disease |
Non-Patent Citations (1)
Title |
---|
《光明中医》 19991231 刘德泉 冠心病的中药运用规律探讨 14-16 1-2 第14卷, 第83期 2 * |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103977244A (en) * | 2014-06-06 | 2014-08-13 | 任杰 | Traditional Chinese medicine for treating coronary heart disease |
CN103977244B (en) * | 2014-06-06 | 2016-09-28 | 吴军 | A kind of Chinese medicine treating coronary heart disease |
CN104474129A (en) * | 2014-11-26 | 2015-04-01 | 张治伦 | Medicinal formula for treating coronary heart disease and use method thereof |
CN105796789A (en) * | 2014-12-14 | 2016-07-27 | 张雪松 | Traditional Chinese medicine preparation for treating coronary heart disease |
Also Published As
Publication number | Publication date |
---|---|
CN101804183B (en) | 2011-06-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103341064B (en) | Chinese medicine composition for treating urine retention | |
CN103007191A (en) | Chinese medicinal composition for treating jaundice | |
CN103341004A (en) | Chinese medicine composition for treating delayed menstrual cycle | |
CN103705866A (en) | Traditional Chinese medicine composition for treating hypomenorrhea | |
CN103349753A (en) | Traditional Chinese medicine composition for treating kidney deficiency | |
CN100460008C (en) | Chinese medicine composition for treating cancer | |
CN101130000A (en) | Traditional Chinese medicine for treating postoperative constipation | |
CN101991752A (en) | Traditional Chinese medicine formula for treating gout | |
CN103316298B (en) | Traditional Chinese composition for treating arthralgia | |
CN103211885A (en) | Chinese medicinal composition for treatment of chronic urticaria | |
CN101987138A (en) | Chinese medicinal preparation for treating impotence | |
CN102048899A (en) | Traditional Chinese medicine preparation for treating impotence | |
CN103272143A (en) | Traditional Chinese medicine composition for treating acne | |
CN101804183B (en) | Medicine for treating coronary heart disease | |
CN104524159A (en) | Pharmaceutical composition for treating hyperplasia of mammary glands | |
CN101912596B (en) | Medicament for treating allergic rhinitis and preparation method thereof | |
CN101912567A (en) | Chinese medicinal prescription for treating chronic myocarditis | |
CN101411799B (en) | Oral medicinal liquor for treating rheumatism and rheumatoid disease | |
CN101164587A (en) | Traditional Chinese medicine for treating palpitation restlessness, chest distress and short breath | |
CN104306848A (en) | Traditional Chinese medicinal composition for treating frequent micturition caused by deficiency of kidney | |
CN101129893A (en) | Traditional Chinese medicine for treating cervical spondylosis with diarrhea | |
CN103721082A (en) | Traditional Chinese medicinal composition for treating scapulohumeral periarthritis | |
CN103316296A (en) | Traditional Chinese medicine composition for treating hyperostosis | |
CN103007213A (en) | Chinese medicinal composition for treating arthralgia | |
CN102579672A (en) | Medicament for treating bone hyperplasia and lumbar disc herniation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C17 | Cessation of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20110629 Termination date: 20140526 |